Opinion|Videos|October 16, 2024

Patient Education and Emerging Therapies

Panelists discuss how health care providers can improve patient education and support for type 2 inflammatory conditions through personalized communication strategies and shared decision-making, while also evaluating the role of emerging biologic therapies in treatment plans based on individual patient factors, disease severity, and biomarker profiles.

  • How can health care providers better educate and support patients in understanding type 2 inflammatory conditions and adhering to treatment plans?
  • What are your perspectives on the emerging biologic therapies targeting type 2 inflammation? How do you determine when these treatments may be appropriate for your patients?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo